Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.36 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250415 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL11131659 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL459228 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL4655596 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL6554402 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL724922 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL3806150 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL1111104 | 0.98 | DNM1 (0.44) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL5936869 | 0.96 | DNM1 (0.42) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL1608844 | 0.96 | DNM1 (0.42) | DNM1LPAR1LPAR3SMPD1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | NISSAN CHEMICAL CORPORATION (JP) | 2023-12-21 | — | — | US | disclosed |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | KYUSHU UNIVERSITY (JP) | 2023-10-03 | — | — | US | disclosed |
| CN-116847871-A | Skin care compositions and methods of use | 现代牧场股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| EP-4230265-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | Nissan Chemical Corporation (JP) | 2023-08-23 | — | — | EP | disclosed |
| EP-3251656-B1 | MOISTURIZING BASE MATERIAL INCLUDING LIPID-PEPTIDE COMPOUND | UNIV KYUSHU (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-20230062111-A1 | ANTI-POLLUTION MATERIAL | NISSAN CHEMICAL CORPORATION (JP) | 2023-03-02 | — | — | US | disclosed |
| EP-3881823-B1 | SOLID BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2023-01-25 | — | — | EP | disclosed |
| EP-4074380-A1 | ANTI-POLLUTION MATERIAL | Nissan Chemical Corporation (JP) | 2022-10-19 | — | — | EP | disclosed |
| US-20220213229-A1 | METHOD FOR PRODUCING MODIFIED CELLULOSE | KAO CORPORATION (JP) | 2022-07-07 | — | — | US | disclosed |
| EP-4014958-A1 | COATING FILM-FORMING COMPOSITION | Nissan Chemical Corporation (JP) | 2022-06-22 | — | — | EP | disclosed |
| EP-2692335-A1 | METHOD FOR PRODUCING COSMETIC, METHOD FOR PREPARING GEL FOR COSMETICS, AND METHOD FOR REDUCING QUANTITY OF HIGH-MOLECULAR THICKENER ADDED TO STARTING MATERIALS OF COSMETIC | Nissan Chemical Industries, Ltd. (JP) | 2014-02-05 | — | — | EP | disclosed |
| EP-2664321-A2 | Medical instrument | Nissan Chemical Industries, Ltd. (JP) | 2013-11-20 | — | — | EP | disclosed |
| US-20130296761-A1 | GEL SHEET CONTAINING LIPID PEPTIDE GELATOR AND POLYMERIC COMPOUND | KYUSHU UNIVERSITY (JP) | 2013-11-07 | — | — | US | disclosed |
| EP-2638921-A1 | GEL SHEET COMPRISING LIPIDIC PEPTIDE TYPE GELLING AGENT AND POLYMERIC COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-20130084305-A1 | COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20120258059-A1 | COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
| EP-2494953-A1 | COSMETIC AND EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT | Nissan Chemical Industries, Ltd. (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20110250248-A1 | External preparation for skin | SHISEIDO COMPANY, LTD. | 2011-10-13 | — | — | US | disclosed |
| US-20090081142-A1 | External Preparation for Skin | SHISEIDO COMPANY LTD. | 2009-03-26 | — | — | US | disclosed |
| EP-1955691-A1 | EXTERNAL PREPARATION FOR SKIN | Shiseido Company, Limited (JP) | 2008-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | CUTA, SCAMP3, SURF4 | DNM1 3894/4885LPAR1 897/4885LPAR3 733/4885 |
| US-20130084305-A1 | COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT | CUTA, F12, SGMS1 | DNM1 2943/4885LPAR1 117/4885LPAR3 264/4885 |
| US-20090081142-A1 | External Preparation for Skin | CUTA, MMS19, ALAD | DNM1 4852/4885LPAR1 2476/4885LPAR3 3180/4885 |
| US-20120258059-A1 | COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT | CUTA, F12, SGMS1 | DNM1 2943/4885LPAR1 117/4885LPAR3 264/4885 |
| US-20230062111-A1 | ANTI-POLLUTION MATERIAL | PLIN3, CUTA, PLIN5 | DNM1 2509/4885LPAR1 512/4885LPAR3 432/4885 |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | NGLY1, NR1H4, HRH1 | DNM1 1818/4885LPAR1 255/4885LPAR3 271/4885 |
| US-20110250248-A1 | External preparation for skin | CUTA, MMS19, ALAD | DNM1 4852/4885LPAR1 2476/4885LPAR3 3180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.